COPD Exacerbations and Increased Cardiovascular Risk

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
In this podcast, Nitin Seam, MD, assistant professor of medicine at George Washington University, talks with Anant Patel, MBBS, MRC clinical research fellow at the Center for Respiratory Medicine, University College London, and Mark Dransfield, MD, associate professor of medicine at UAB School of Medicine and medical director of the UAB Lung Health Center, about a new study of the link between acute exacerbations of COPD and cardiovascular risk.

To listen to this podcast, click here.
Related Articles
The FDA’s Cardiovascular and Renal Drugs Advisory Committee has recommended the approval of edoxaban (Savaysa) for treating patients with nonvalvular atrial fibrillation, a type of arrhythmia that can potentially cause a stroke.
Even though smoking can exacerbate respiratory conditions and limit the efficacy of their treatment, patients often purchase cigarettes while filling prescriptions for asthma or antihypertensive drugs at pharmacies.
Patients with moderate-to-severe psoriasis are more likely to have uncontrolled hypertension.
The disease burden of smoking remains immense despite widespread tobacco cessation efforts.
Latest Issues
$auto_registration$